The following list provides information on adverse reactions reported in study MF 4411 occurring more frequently with ibandronic acid 2.5 mg daily than with placebo and study BM 16549 occurring more frequently with Bondenza 150 mg once monthly than with ibandronic acid 2.5 mg daily.